FAQ/Help |
Calendar |
Search |
Today's Posts |
|
ALS News & Research For postings of news or research links and articles related to ALS |
Reply |
|
Thread Tools | Display Modes |
|
04-04-2016, 10:49 AM | #1 | |||
|
||||
Grand Magnate
|
Neuraltus Pharmaceuticals Announces Plans for Second Phase 2 Study of NP001 in ALS Using Biomarker for Enriched Patient Selection
http://www.prnewswire.com/news-relea...300245076.html |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
NeuroDerm Announces Enrollment in a 2nd Phase 2 Study of ND0612 - Continuous L/C Drug | Parkinson's Disease | |||
NeuroDerm Announces Enrollment in a Phase 2 Study of ND0612, a Continuous Levodopa/Ca | Parkinson's Disease | |||
NeuroDerm Announces Enrollment in a Phase 1 Study of ND0612, a Continuous Levodopa/Ca | Parkinson's Disease | |||
Rexahn Pharmaceuticals Announces Publication of Study on Neuroprotective Effects of C | Parkinson's Disease |